Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. RS Herbst, SG Eckhardt, R Kurzrock, S Ebbinghaus, PJ O'Dwyer, ... | 512 | 2010 |
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal … AM Jubb, HI Hurwitz, W Bai, EB Holmgren, P Tobin, AS Guerrero, ... Journal of clinical oncology 24 (2), 217-227, 2006 | 471 | 2006 |
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab WL Ince, AM Jubb, SN Holden, EB Holmgren, P Tobin, M Sridhar, ... Journal of the National Cancer Institute 97 (13), 981-989, 2005 | 399 | 2005 |
Biomarkers to predict the clinical efficacy of bevacizumab in cancer AM Jubb, AL Harris The lancet oncology 11 (12), 1172-1183, 2010 | 357 | 2010 |
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients Z Jiang, S Jhunjhunwala, J Liu, PM Haverty, MI Kennemer, Y Guan, ... Genome research 22 (4), 593-601, 2012 | 303 | 2012 |
Predicting benefit from anti-angiogenic agents in malignancy AM Jubb, AJ Oates, S Holden, H Koeppen Nature Reviews Cancer 6 (8), 626-635, 2006 | 296 | 2006 |
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung RN Fuji, M Flagella, M Baca, MA S. Baptista, J Brodbeck, BK Chan, ... Science translational medicine 7 (273), 273ra15-273ra15, 2015 | 292 | 2015 |
Neuropilin‐1 expression in cancer and development AM Jubb, LA Strickland, SD Liu, J Mak, M Schmidt, H Koeppen The Journal of pathology 226 (1), 50-60, 2012 | 240 | 2012 |
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells CC Ong, AM Jubb, PM Haverty, W Zhou, V Tran, T Truong, H Turley, ... Proceedings of the National Academy of Sciences 108 (17), 7177-7182, 2011 | 239 | 2011 |
Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab PS Hegde, AM Jubb, D Chen, NF Li, YG Meng, C Bernaards, R Elliott, ... Clinical Cancer Research 19 (4), 929-937, 2013 | 230 | 2013 |
The histone demethylase JMJD2B is regulated by estrogen receptor α and hypoxia, and is a key mediator of estrogen induced growth J Yang, AM Jubb, L Pike, FM Buffa, H Turley, D Baban, R Leek, KC Gatter, ... Cancer research 70 (16), 6456-6466, 2010 | 202 | 2010 |
Expression of vascular endothelial growth factor, hypoxia inducible factor 1α, and carbonic anhydrase IX in human tumours AM Jubb, TQ Pham, AM Hanby, GD Frantz, FV Peale, TD Wu, ... Journal of clinical pathology 57 (5), 504-512, 2004 | 198 | 2004 |
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers D Gray, AM Jubb, D Hogue, P Dowd, N Kljavin, S Yi, W Bai, G Frantz, ... Cancer research 65 (21), 9751-9761, 2005 | 195 | 2005 |
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis AM Jubb, FM Buffa, AL Harris Journal of cellular and molecular medicine 14 (1‐2), 18-29, 2010 | 178 | 2010 |
Methylation and colorectal cancer AM Jubb, SM Bell, P Quirke The Journal of pathology 195 (1), 111-134, 2001 | 174 | 2001 |
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia AM Jubb, S Chalasani, GD Frantz, R Smits, HI Grabsch, V Kavi, ... Oncogene 25 (24), 3445-3457, 2006 | 162 | 2006 |
Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae JA McKinnell, JP Dwyer, GH Talbot, LE Connolly, I Friedland, A Smith, ... New England Journal of Medicine 380 (8), 791-793, 2019 | 157 | 2019 |
p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model HY Chow, AM Jubb, JN Koch, ZM Jaffer, D Stepanova, DA Campbell, ... Cancer research 72 (22), 5966-5975, 2012 | 147 | 2012 |
Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer AM Jubb, H Turley, HC Moeller, G Steers, C Han, JL Li, R Leek, EY Tan, ... British journal of cancer 101 (10), 1749-1757, 2009 | 147 | 2009 |
Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer AM Jubb, EJ Soilleux, H Turley, G Steers, A Parker, I Low, J Blades, JL Li, ... The American journal of pathology 176 (4), 2019-2028, 2010 | 142 | 2010 |